158 related articles for article (PubMed ID: 7382540)
1. Ethambutol compared to rifampin in original treatment of pulmonary tuberculosis.
Bobrowitz ID
Lung; 1980; 157(3):117-25. PubMed ID: 7382540
[No Abstract] [Full Text] [Related]
2. Preliminary results of six-month regimens studied in the United States and in Poland.
Snider D; Long M; Zierski M; Rogowski J; Bek E
Chest; 1981 Dec; 80(6):727-9. PubMed ID: 7307596
[No Abstract] [Full Text] [Related]
3. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
[No Abstract] [Full Text] [Related]
4. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
Chioléro R
Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
[No Abstract] [Full Text] [Related]
5. [The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids].
Kuntz HD; Rausch V; Bammel E
Med Welt; 1978 Mar; 29(11):452-4. PubMed ID: 651600
[No Abstract] [Full Text] [Related]
6. Isoniazid-rifampin-induced hepatitis in hepatitis B carriers.
Wu JC; Lee SD; Yeh PF; Chan CY; Wang YJ; Huang YS; Tsai YT; Lee PY; Ting LP; Lo KJ
Gastroenterology; 1990 Feb; 98(2):502-4. PubMed ID: 2295408
[TBL] [Abstract][Full Text] [Related]
7. Treatment of pulmonary tuberculosis.
Byrd RB; Kaplan PD; Gracey DR
Chest; 1974 Nov; 66(5):560-7. PubMed ID: 4139002
[No Abstract] [Full Text] [Related]
8. Antituberculosis agents.
Goldberger MJ
Med Clin North Am; 1988 May; 72(3):661-8. PubMed ID: 3280912
[TBL] [Abstract][Full Text] [Related]
9. Short-course chemotherapy. The Arkansas experience.
Dutt AK; Stead WW
Chest; 1981 Dec; 80(6):724-7. PubMed ID: 7030655
[No Abstract] [Full Text] [Related]
10. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
Konno K; Oizumi K; Yamada S; Ogata K; Sato M
Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
[No Abstract] [Full Text] [Related]
11. Isoniazid administration and liver injury.
Rudoy R; Stuemky J; Poley JR
Am J Dis Child; 1973 May; 125(5):733-6. PubMed ID: 4266968
[No Abstract] [Full Text] [Related]
12. Daily and intermittent short-course regimens in the original treatment of pulmonary tuberculosis. Preliminary results. Cooperative comparative clinical study in Poland.
Zierski M
Scand J Respir Dis Suppl; 1978; 102():48-52. PubMed ID: 278215
[No Abstract] [Full Text] [Related]
13. [Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
Kuntz HD; Rausch V
Prax Klin Pneumol; 1977 Nov; 31(11):925-32. PubMed ID: 928291
[No Abstract] [Full Text] [Related]
14. [Proceedings: Rifampicin in initial therapy of pulmonary tuberculosis].
Gyselen A; Cosemans J; Lacquet L; Verbist L
Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):128-35. PubMed ID: 4491709
[No Abstract] [Full Text] [Related]
15. Ambulatory management of tuberculosis.
Hampton JR; Bates JH
Am Fam Physician; 1974 Nov; 10(5):204-10. PubMed ID: 4214055
[No Abstract] [Full Text] [Related]
16. Initial treatment of tuberculosis with rifampicin.
O'Connell J; Campbell AH; Cowen K; Verins A
Med J Aust; 1973 Nov; 2(19):881-5. PubMed ID: 4765873
[No Abstract] [Full Text] [Related]
17. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F
Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070
[TBL] [Abstract][Full Text] [Related]
18. Treatment of isoniazid-resistant pulmonary tuberculosis with ethambutol, rifampicin and capreomycin: a co-operative study in England and Wales.
Andrews RH; Jenkins PA; Marks J; Pines A; Selkon JB; Somner AR
Tubercle; 1974 Jun; 55(2):105-13. PubMed ID: 4143450
[No Abstract] [Full Text] [Related]
19. Modern management of tuberculosis.
Promisloff RA; Johnston RF
Compr Ther; 1979 Oct; 5(10):25-37. PubMed ID: 498742
[No Abstract] [Full Text] [Related]
20. Paradoxical worsening in tuberculosis during therapy in an HIV-infected patient.
Mofredj A; Guérin JM; Leibinger F; Masmoudi R
Infection; 1996; 24(5):390-1. PubMed ID: 8923052
[No Abstract] [Full Text] [Related]
[Next] [New Search]